tiprankstipranks
Trending News
More News >
VistaGen Therapeutics (VTGN)
NASDAQ:VTGN
US Market

VistaGen Therapeutics (VTGN) Revenue

Compare
1,166 Followers

VistaGen Therapeutics Revenue

VistaGen Therapeutics had a revenue of 303.00K in the quarter ending Dec 31, 2025, with 17.44%. This bring the company's revenue in the last twelve months to 790.00K, Decreased 9.57%. In the fiscal year ending Mar 31, 2025, VistaGen Therapeutics had annual revenue of 486.00K with -54.32% growth.
Revenue (ttm)
790.00K
Revenue Growth
-33.00%
P/S Ratio
49.54
Revenue/Employee
$10,125
Employees
48
Market Cap
$24.08M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Mar 31, 2025
486.00K-578.00K-54.32%
Mar 31, 2024
1.06M1.29M-568.72%
Mar 31, 2023
-227.00K-1.34M-120.47%
Mar 31, 2022
1.11M19.40K+1.78%
Mar 31, 2021
1.09M+∞%
Mar 31, 2020
Mar 31, 2019
Mar 31, 2018
-1.25M-100.00%
Mar 31, 2017
1.25M